[Therapeutic approaches to non-erosive GERD--comparison between the Western countries and Japan]

Michio Hongo1, Masashi Adachi

  • 1Department of Comprehensive Medicine, Tohoku University Hospital.

Insights

Patients with heartburn but no visible esophageal damage, known as non-erosive reflux disease (NERD), may experience more severe symptoms and be less responsive to treatment in Western countries compared to Japan.

Area of Science:

  • Gastroenterology
  • Reflux Esophagitis Research

Background:

  • Heartburn is a common symptom that can occur without visible esophageal damage.
  • This condition is referred to as endoscopy-negative GERD, non-erosive reflux disease (NERD), or symptomatic-GERD.
  • NERD is increasingly recognized as a distinct clinical entity.

Purpose of the Study:

  • To explore the characteristics and prevalence of non-erosive reflux disease (NERD).
  • To compare symptom severity and treatment resistance of NERD between Western countries and Japan.
  • To investigate potential factors contributing to observed differences.

Main Methods:

  • Review of clinical data and patient-reported outcomes for individuals with heartburn.
  • Comparative analysis of NERD prevalence and symptomology across different geographical regions.
  • Exploration of potential etiological factors including diet and co-occurring functional gastrointestinal disorders.

Main Results:

  • Heartburn symptoms may be more severe in patients from Europe and the United States compared to Japan.
  • Non-erosive reflux disease (NERD) patients appear more resistant to pharmacotherapy and surgical interventions.
  • NERD appears more prevalent in Western populations than in Japan.

Conclusions:

  • Geographical variations exist in the presentation and management of non-erosive reflux disease (NERD).
  • Dietary habits and the potential overlap with functional gastrointestinal disorders may contribute to these differences.
  • Further research is needed to elucidate the underlying mechanisms and optimize treatment strategies for NERD.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...